介入溶栓联合内支架置入术治疗颈内动脉急性闭塞  

作　　者：周军[1] 马强[1] 赵广生[1] 袁琳[1] 于颖[1] 张跃伟[1] 

机构地区：[1]大连大学附属中山医院,110001

出　　处：《当代医学》2011年第31期14-15,共2页Contemporary Medicine

摘　　要：目的探讨应用介入溶栓联合内支架置入术(Carotidangioplastyandstenting,CAS)治疗颈动脉急性闭塞患者的疗效和安全性。方法从2008年6月～2009年6月对5例颈动脉急性闭塞患者进行CAS治疗,观察CAS的疗效和并发症。结果 5例颈动脉急性闭塞患者成功进行了CAS治疗,颈内动脉介入术后的平均狭窄率减少到31.2%。术中1例患者发生了一过性心率减慢和血压下降,对症处理后好转。经过10～22(14.7±2.5)月的随访,所有患者没有再发卒中,5例患者通过影像学随访,管腔通畅,无再狭窄或者闭塞发生。结论颈动脉急性闭塞急诊行CAS,降低了管腔再闭塞发生率,提高了临床疗效,其远期疗效和安全性需要作进一步大样本研究。Objective To investigate the efficacy and the complication of carotid angioplasty and stenting （CAS） in patients with acute carotid ischemic stroke.Methods From June 2008 to June 2009.5 patients with acute carotid ischemic stroke underwent CAS,the efficacy and complications of CAS were observed and concluded.Results 5 cases of acute carotid ischemic stroke were treated with CAS.Stenotic rate was significantly reduced to 31.2% immediately after CAS.One patients had mild and reversible low heart rateand blood pressure.During follow-up for 10～22 （14.7±2.5） months,no case had stroke again,all except one had no dizziness or vertigo again.Ultrasonography and/or computed tomographic angiography showed no restenosis in 5 cases when they were followed up.Conclusion CAS with cerebral protection device is a safe and feasible procedure to treat acute carotid ischemic stroke.However,its long-term efficacy and safety need to be further studied.

关 键 词：颈内动脉 闭塞性病变 血管支架 介入治疗 并发症 

分 类 号：R654.3[医药卫生—外科学]